Ensign Peak Advisors’s Prime Medicine PRME Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-103,190
| Closed | -$530K | – | 1715 |
|
|
2024
Q2 | $530K | Sell |
103,190
-46,810
| -31% | -$241K | ﹤0.01% | 1586 |
|
|
2024
Q1 | $1.05M | Hold |
150,000
| – | – | ﹤0.01% | 1284 |
|
|
2023
Q4 | $1.33M | Hold |
150,000
| – | – | ﹤0.01% | 1169 |
|
|
2023
Q3 | $1.43M | Hold |
150,000
| – | – | ﹤0.01% | 951 |
|
|
2023
Q2 | $2.2M | Hold |
150,000
| – | – | ﹤0.01% | 836 |
|
|
2023
Q1 | $1.85M | Hold |
150,000
| – | – | ﹤0.01% | 881 |
|
|
2022
Q4 | $2.79M | Buy |
+150,000
| New | +$2.79M | 0.01% | 715 |
|